Systemic Lupus Erythematosus

Stem cells from cord blood are being investigated as a possible to assist patient with SLE. Click on the link provided to find out more about the trial. It remains too early to know if the approach will be suitable. We need evidence collected in clinical trials to determine if a proposed stem cell treatment is both safe and effective.

tagged as Systemic Lupus Erythematosus

  • Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus Location: China
    Overview: This trial aims to evaluate the use of umbilical cord stem cells in treating active, refractory Systemic Lupus Erythematosus. The trial is being conducted by the Affiliated Nanjing Drum Tower Hospital and Nanjing University Medical School and proposes to recruit 40 patients between January 2012 and December 2013. Participants will receive an infusion of mesenchymal stem cells obtained from donated umbilical cord blood. Participants will be monitored for complications following the injection and changes in clinical condition, including lupus serology and kidney function.
    Link to Clinical Registry
    Trial Design: Safety and Efficacy Study
    Status: Open - Recruiting
    Stem Cell: Umbilical Cord Stem Cells